Evofem Biosciences (EVFM) Stock Chart & Stock Price History $0.0094 +0.00 (+4.44%) As of 05/21/2025 01:28 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock Evofem Biosciences Stock Price Performance The Evofem Biosciences (EVFM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 27.02%, with a year-to-date return of -5.05%. In the past month, the stock has decreased 2.08%, reflecting recent market activity. As of the latest close, Evofem Biosciences traded at $0.01 with a market cap of $1.07 million and volume of 111,204 shares. Five years ago, the stock traded at a split-adjusted price of $9,356.25, representing a 100.00% decrease over that period. At the time, it had a market cap of $240.15 million and a volume of 51,428 shares. Receive EVFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.17%1 Month Performance-2.08%3 Month Performance+2.17%Year-To-Date Performance-5.05%1 Year Performance-27.02%5 Year Performance-100.00% EVFM Stock Chart for Thursday, May, 22, 2025 EVFM Chart by TradingView Evofem Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$0.01$0.01+4.44%$0.01$0.01111,204 shs$1.07 million05/20/2025$0.01$0.01-3.23%$0.01$0.01169,973 shs$1.02 million05/19/2025$0.01$0.01+1.09%$0.01$0.01130,302 shs$1.05 million05/16/2025$0.01$0.01+1.10%$0.01$0.0169,514 shs$1.04 million05/15/2025$0.01$0.01+8.33%$0.01$0.01143,201 shs$1.03 million05/14/2025$0.01$0.01$0.01$0.0125,086 shs$952,000.0005/13/2025$0.01$0.01-2.33%$0.01$0.0179,762 shs$952,000.0005/12/2025$0.01$0.01+1.18%$0.01$0.01280,436 shs$975,000.0005/09/2025$0.01$0.01-1.16%$0.01$0.01368,142 shs$964,000.0005/08/2025$0.01$0.01+2.38%$0.01$0.0112,495 shs$975,000.00 Get the Latest News and Ratings for EVFM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$0.01$0.01-2.33%$0.01$0.0194,915 shs$952,000.0005/06/2025$0.01$0.01-8.51%$0.01$0.01933,121 shs$975,000.0005/05/2025$0.01$0.01+4.44%$0.01$0.01152,607 shs$1.07 million05/02/2025$0.01$0.01+4.65%$0.01$0.01137,310 shs$1.02 million05/01/2025$0.01$0.01-2.27%$0.01$0.01141,402 shs$975,000.0004/30/2025$0.01$0.01-3.30%$0.01$0.0130,614 shs$998,000.0004/29/2025$0.01$0.01+5.81%$0.01$0.0123,202 shs$1.03 million04/28/2025$0.01$0.01-4.44%$0.01$0.01117,002 shs$975,000.0004/25/2025$0.01$0.01-1.10%$0.01$0.01222,890 shs$1.02 million04/24/2025$0.01$0.01-4.21%$0.01$0.01125,199 shs$1.03 million04/23/2025$0.01$0.01-1.04%$0.01$0.019,062 shs$1.08 million04/22/2025$0.01$0.01+3.23%$0.01$0.01126,540 shs$1.09 million04/21/2025$0.01$0.01+3.33%$0.01$0.01445,410 shs$1.05 million Related Companies Sonnet BioTherapeutics Stock Price Chart Galecto Stock Price Chart Titan Pharmaceuticals Stock Price Chart Sunshine Biopharma Stock Price Chart Jaguar Health Stock Price Chart Matinas Biopharma Stock Price Chart PainReform Stock Price Chart Mustang Bio Stock Price Chart Tharimmune Stock Price Chart CNS Pharmaceuticals Stock Price Chart Receive EVFM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evofem Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EVFM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredWarning: Prepare to Be Shocked by These PayoutsThere's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evofem Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evofem Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
